Daniel F. Wallace
About
In The Last Decade
Daniel F. Wallace
81 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 126
- Hematology 1.6k
- Genetics 1.3k
- Nutrition and Dietetics 1.2k
- Molecular Biology 249
- Rheumatology 143
Countries citing papers authored by Daniel F. Wallace
This map shows the geographic impact of Daniel F. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel F. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel F. Wallace more than expected).
Fields of papers citing papers by Daniel F. Wallace
This network shows the impact of papers produced by Daniel F. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel F. Wallace. The network helps show where Daniel F. Wallace may publish in the future.
Co-authorship network of co-authors of Daniel F. Wallace
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel F. Wallace. A scholar is included among the top collaborators of Daniel F. Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel F. Wallace. Daniel F. Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 10 | |
| 4 | 46 | |
| 5 | 9 | |
| 6 | The regulation of iron absorption and homeostasis | 173 |
| 7 | Endofin, a novel BMP-SMAD regulator of the iron-regulatory hormone, hepcidin | 1 |
| 8 | Analysis of IL-22 contribution to hepcidin induction and hypoferremia during the response to LPS in vivo | 6 |
| 9 | 54 | |
| 10 | New genetic complexity underlying atypical iron disorders | 2 |
| 11 | 35 | |
| 12 | Temporal and tissue-specific analysis of iron loading in mouse models of hereditary haemochromatosis | 2 |
| 13 | The Efficacy and Safety of Abatacept in SLE: Results of a 12-month Exploratory Study | 15 |
| 14 | 124 | |
| 15 | 22 | |
| 16 | Inactivation of the murine Transferrin Receptor 2 gene using the cre recombinase: loxP system | 3 |
| 17 | 2 | |
| 18 | 71 | |
| 19 | A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote | 2 |
| 20 | A simple genetic test identifies 90% of UK patients with haemochromatosis | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.